Skip to content

Category: macular degenerationSyndicate content

Breeding better broccoli

November 4, 2009

CHARLESTON, SC -- Carotenoids -- fat-soluble plant compounds found in some vegetables -- are essential to the human diet and reportedly offer important health benefits to consumers.

Study finds lack of VEGF can cause defects similar to dry macular degeneration

November 2, 2009

Boston, MA -- Scientists at Schepens Eye Research Institute have found that when the eye is missing a diffusible form of vascular endothelial growth factor (VEGF), i.e.

Cataract surgery helps AMD patients; steroid improves DME; online eye health forum

November 1, 2009

SAN FRANCISCO, CA--- This month's Ophthalmology, the journal of the American Academy of Ophthalmology (Academy) reports on a national study that finds cataract surgery is likely to benefit p

Blue light-filtering increases macular pigment, may protect against age-related vision loss

October 26, 2009

Waterford City, Ireland, October 26, 2009 -- Results of an important new study show that implantation of blue light-filtering intraocular lens (IOLs) at the time of cataract surgery increases a nu

Experimental treatments restore partial vision to blind people

October 20, 2009

Two experimental treatments, a retinal prosthesis and fetal tissue transplant, restored some vision to people with blinding eye diseases. The findings, presented at Neuroscience 2009, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news on brain science and health, may lead to new treatments for the blind.

Researchers discover mechanism that helps humans see in bright and low light

October 13, 2009

Oct. 13, 2009 -- Ever wonder how your eyes adjust during a blackout? When we go from light to near total darkness, cells in the retina must quickly adjust. Vision scientists at Washington University School of Medicine in St. Louis have identified an intricate process that allows the human eye to adapt to darkness very quickly.

Cancer drug is no different in effectiveness as gold standard treatment for macular degeneration

October 9, 2009

(Boston) - Investigators from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have shown, at 6 months in a small group of patients, that there is no difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD).

Study examines use of clinical and cost-effectiveness data for drug coverage decisions

October 6, 2009

A comparison of national agencies that play a role in determining drug coverage decisions in Britain, Canada and Australia finds that uncertainty regarding clinical effectiveness is a key issue in coverage decisions, with other factors including the ability to negotiate price and societal values, according to a study in the October 7 issue of JAMA.

Designing drugs and their antidotes together improves patient care

October 4, 2009

DURHAM, N.C. -- Imagine a surgical patient on a blood-thinning drug who starts bleeding more than expected, and an antidote that works immediately -- because the blood thinner and antidote were designed to work together.

Retinal rescue: Cells derived from human embryonic stem cells reverse retinal degeneration

October 1, 2009

A new study reports that transplanted pigment-containing visual cells derived from human embryonic stem cells (hESCs) successfully preserved structure and function of the specialized light-sensitive lining of the eye (known as the retina) in an animal model of retinal degeneration.

Positive trend for diabetic eye health; AMD may predict heart disease; vision impacts life success

October 1, 2009

SAN FRANCISCO, CA?Highlights of October's Ophthalmology, the journal of the American Academy of Ophthalmology, include good news on preserving vision in people with type 1 diabetes, a warning from the Cardiovascular Health Study for macular degeneration patients, and a report on how vision impacts well-being across the lifespan.

MIT retinal implant could help restore some vision

September 23, 2009

Results: MIT engineers have designed a retinal implant for people who have lost their vision from retinitis pigmentosa or age-related macular degeneration, two of the leading causes of blindness. The retinal prosthesis would help restore some vision by electrically stimulating the nerve cells that normally carry visual input from the retina to the brain.

Counting duplicated genome segments now possible

August 30, 2009

A newly designed computational method has proven its usefulness in counting copies of duplicated genome sequences and in doing initial assessments of their contents, according to a study to be published Aug. 30 in Nature Genetics. The number of copies of particular DNA segments can differ from one person to the next.

Painless 'microneedle' patch may take the sting out of shots

August 19, 2009

WASHINGTON, Aug. 19, 2009 -- Good news for people fearful of needles and squeamish of shots: Scientists at the 238th National Meeting of the American Chemical Society report the design of a painless patch that may someday render hypodermic needles -- as well as annual flu shots -- a thing of the past.

Pharmacy pamphlets apparently more about looks than legibility: study

August 6, 2009

It seems like common sense that an information leaflet for vision loss would have large print and appropriate contrast, but that's not the case a new study done at the University of Alberta has found.



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.